Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/62486| metadata.dc.identifier.doi: | https://doi.org/10.56042/jsir.v82i9.2180 |
| Title: | Profitability Study of Indian Pharmaceutical Industry: A Co Integration Approach |
| Authors: | Mahor, Nirbhay Banerji, Amit |
| Keywords: | Export intensity;Physical capital intensity;Leverage;Research and development intensity;Working capital management |
| Issue Date: | Sep-2023 |
| Publisher: | NIScPR-CSIR, India |
| Abstract: | Profitability (ROA) study of the Indian pharmaceutical industry has been studied under dynamic conditions to avoid endogeneity issues. Vector Error Correction Mode (VECM) results suggest short-run and long-run dependency of profitability on working capital intensity, research & development intensity, and physical capital intensity. Physical capital intensity exhibited a negative impact on ROA. Auto Regressive Distributed Lag (ARDL) results suggest short-run and longrun positive dependency on research & development intensity, working capital intensity, and leverage on profitability. Granger causality with two lags from fixed assets invested on net profits along with a strong positive correction suggests a longer payback period. This sector will require continuously high investments in physical capital intensity, operating capital, and research & development. Financing through debt can be undertaken with profitability but with prudence. |
| Page(s): | 973-982 |
| ISSN: | 0022-4456 (Print); 0975-1084 (Online) |
| Appears in Collections: | JSIR Vol.82(09) [September 2023] |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| JSIR (82)09 973-982.pdf | 1.12 MB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.